S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Your Money is Not Safe (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The “Perfect Storm” for Gold (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Bitcoin Rockets To Record High But Buy THIS Instead (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Your Money is Not Safe (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The “Perfect Storm” for Gold (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Bitcoin Rockets To Record High But Buy THIS Instead (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Your Money is Not Safe (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The “Perfect Storm” for Gold (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Bitcoin Rockets To Record High But Buy THIS Instead (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Your Money is Not Safe (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The “Perfect Storm” for Gold (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Bitcoin Rockets To Record High But Buy THIS Instead (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial
OTCMKTS:NRXGQ

NephroGenex (NRXGQ) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)
Free NRXGQ Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2,000 shs
Average Volume
26,223 shs
Market Capitalization
$36,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
NRXGQ stock logo

About NephroGenex Stock (OTCMKTS:NRXGQ)

NephroGenex, Inc. is a pharmaceutical company. The Company is focused on the development of therapeutics to treat kidney disease. The Company has paused the clinical program of its product candidate, oral Pyridorin, for the treatment of diabetic nephropathy. The Company was primarily focused on the Phase III Pyridorin program, and other planned clinical and nonclinical studies and other work needed to submit Pyridorin for acute kidney injury (AKI), as well as the treatment of diabetic nephropathy in patients with Type II diabetes for regulatory approval in the United States and Europe. The Company has not generated any revenues.

NRXGQ Stock News Headlines

August 24, 2023 | investing.com
Elicera Therapeutics AB (ELIC)
August 17, 2023 | investing.com
LL Lucky Games publ AB (LADYLU)
April 19, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
July 13, 2023 | investing.com
Xinjiang Daqo New Energy Co Ltd (688303)
July 12, 2023 | investing.com
Tsukuba Bank Ltd (8338)
July 11, 2023 | investing.com
PEXA Group Ltd (PXA)
June 21, 2023 | investing.com
Kosei Securities Co Ltd (8617)
May 19, 2023 | investing.com
Nusatama Berkah Tbk PT (NTBK)
April 19, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
May 19, 2023 | investing.com
Olympic Group Corp (8289)
May 18, 2023 | investing.com
Shandong Sanyuan Biotechnology Co Ltd (301206)
May 18, 2023 | investing.com
Okinawa financial Group Inc (7350)
May 18, 2023 | investing.com
Selvas Healthcare Inc (208370)
May 16, 2023 | investing.com
Al-Bad Massuot Yitzhak Ltd (ALBA)
May 16, 2023 | investing.com
Seven Utilities and Power PCL (7UP)
May 16, 2023 | investing.com
Yong Pyong Resort Corp (070960)
May 16, 2023 | investing.com
Aksa Enerji Uretim AS (AKSEN)
May 16, 2023 | investing.com
MHP Hotel AG (CDZ0)
March 30, 2023 | marketwatch.com
Renal Disease Market | Insights and Opportunities for 2023-2030
See More Headlines
Receive NRXGQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NephroGenex and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Manufacturing
Industry
Electronic Computer Manufacturing
Sub-Industry
N/A
Current Symbol
OTCMKTS:NRXGQ
Previous Symbol
NASDAQ:NRX
CUSIP
N/A
CIK
1338095
Web
www.nephrogenex.com
Phone
+1-609-5538887
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
12,950,000
Free Float
N/A
Market Cap
$36,000.00
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover
5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • John P. Hamill CPA
    Chief Executive Officer, Chief Financial Officer

Key Competitors

View All Competitors

NRXGQ Stock Analysis - Frequently Asked Questions

How do I buy shares of NephroGenex?

Shares of NRXGQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:NRXGQ) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Your Money is Not Safe
American Alternative
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets